{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion specifically asks if the response suggests the UK can claim Patent Box relief on its \\\"CSA share\\\" (e.g., its 30% contribution) within the context of a Cost Contribution Arrangement (CCA). The candidate answer discusses a CSA/Profit-Split model extensively, focusing on how the UK entity (UKCo) earns a 'routine return' (5-10% markup on costs) for its R&D contributions. It does not explicitly mention or address the UK entity claiming Patent Box relief on this routine return or CSA share. Therefore, the specific condition of the criterion is not met.\", \"criterion_id\": \"43cc9d52-aab4-439e-9d4e-51dd3f4c2a07\"}", "usage": {"prompt_tokens": 2548, "completion_tokens": 175, "total_tokens": 2723}, "latency_s": 0.7679722079774365, "request_id": "Pf2Uabi0N5nqkdUP3rjkuQo", "raw_response": null}